Doug Ostrover, cofounder, co-CEO, and chairman of Blue Owl Capital, helped build one of the most influential private credit platforms of the modern era by scaling Owl Rock into a global alternative asset manager. A former senior executive at Blackstone and cofounder of GSO Capital Partners, Ostrover launched Owl Rock in 2016 with a focus on direct lending and institutional-scale private credit, then helped transform it into Blue Owl through a landmark merger. Known for disciplined underwriting, permanent-capital strategy, and deep institutional relationships, he has become a central figure in the rise of private credit as a core asset class.

Ken Langone, cofounder of Home Depot, is one of America’s most respected entrepreneurs and dealmakers, helping turn a radical big-box retail concept into one of the largest home-improvement chains in the world. After early success on Wall Street as an investment banker, Langone helped finance and launch Home Depot in 1978, and the company’s explosive growth made him a billionaire. Known for his blunt, patriotic style and deep loyalty to employees, he is also a major philanthropist—funding medical research, education, and veterans’ causes, including a landmark gift to make tuition free at NYU’s medical school. Langone remains a prominent voice on business, capitalism, and civic leadership.

Joseph Edelman, founder and CEO of Perceptive Advisors, is one of the most successful and influential biotech hedge fund managers of the modern era. Since launching the firm in 1999, he has built Perceptive into a multibillion-dollar powerhouse specializing in life sciences, backing breakthrough companies across biotechnology, medical devices, and healthcare innovation. Known for his deep scientific understanding, high-conviction portfolio strategy, and early identification of transformative therapies, Edelman has consistently ranked among the top performers in healthcare investing. His disciplined, research-driven approach has made Perceptive a critical source of capital for emerging biotech and a defining force in the global life sciences ecosystem.

Glenn Saldanha, chairman and managing director of Glenmark Pharmaceuticals, has guided the India-based company into a global player in generics, specialty medicines, and innovative drug discovery. Since taking leadership in 2001, he has expanded Glenmark’s presence to over 80 countries, strengthened its R&D capabilities, and advanced its pipeline in oncology, dermatology, and respiratory therapies. With a blend of entrepreneurial drive and scientific focus, Saldanha has positioned Glenmark as a respected name in the international pharmaceutical industry while continuing his family’s legacy in healthcare.

Lorenzo Fertitta is an American businessman, entrepreneur, and philanthropist best known for his role in transforming the Ultimate Fighting Championship (UFC) into a global sports phenomenon. As a co-founder of Zuffa, LLC, and former CEO of UFC, Fertitta has had a significant impact on the sports and entertainment industry. His business acumen extends to gaming, hospitality, and investments, positioning him as one of the most influential figures in modern sports management.